These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 289860

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract] [Full Text] [Related]

  • 23. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH, Hollenberg NK, Moore TJ, Swartz SL, Dluhy RG.
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [Abstract] [Full Text] [Related]

  • 24. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 Mar; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 26. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB, Wallace JM, Laragh JH.
    Kidney Int Suppl; 1979 Mar 12; (9):S107-114. PubMed ID: 225598
    [No Abstract] [Full Text] [Related]

  • 27. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V, Barbour BH, Campese V, Finck EJ, Miano L, Esler M.
    Mayo Clin Proc; 1977 Jun 12; 52(6):369-73. PubMed ID: 865132
    [Abstract] [Full Text] [Related]

  • 28. Hypertension associated with hyperparathyroidism is not responsive to angiotensin blockade.
    Zawada ET, Brickman AS, Maxwell MH, Tuck M.
    J Clin Endocrinol Metab; 1980 May 12; 50(5):912-5. PubMed ID: 6989846
    [Abstract] [Full Text] [Related]

  • 29. Pharmacologic probes to identify patients with renovascular hypertension.
    Sosa RE, Vaughan ED.
    Semin Urol; 1985 Nov 12; 3(4):317-24. PubMed ID: 2887024
    [Abstract] [Full Text] [Related]

  • 30. Physiologic definition of blood pressure response to renal revascularization in patients with renovascular hypertension.
    Vaughan ED, Carey RM, Ayers CR, Peach MJ, Tegtmeyer CJ, Wellons HA.
    Kidney Int Suppl; 1979 Mar 12; (9):S83-92. PubMed ID: 289868
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M, Bichara M, Grüfeld JP, Barbanel C, Meyer P, Funck-Brentano JL.
    Nouv Presse Med; 1978 Feb 18; 7(7):539-43. PubMed ID: 643579
    [Abstract] [Full Text] [Related]

  • 32. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.
    Linas SL, Miller PD, McDonald KM, Stables DP, Katz F, Weil R, Schrier RW.
    N Engl J Med; 1978 Jun 29; 298(26):1440-4. PubMed ID: 349389
    [Abstract] [Full Text] [Related]

  • 33. Saralasin for diagnosis of renovascular hypertension.
    Med Lett Drugs Ther; 1982 Jan 08; 24(600):3-4. PubMed ID: 7054649
    [No Abstract] [Full Text] [Related]

  • 34. Renin angiotensin involvement in transient hypertension after renal injury.
    Elias AN, Anderson GH, Dalakos TG, Streeten DH.
    J Urol; 1978 Apr 08; 119(4):561-2. PubMed ID: 650771
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Saralasin testing for renin-dependent hypertension.
    Weber MA.
    Arch Intern Med; 1979 Jan 08; 139(1):93-5. PubMed ID: 760691
    [No Abstract] [Full Text] [Related]

  • 37. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F, Messore T, Catzola A, Corvino A, Genovese A, Catalano M, Mercone G.
    Recenti Prog Med; 1983 Apr 08; 74(4):415-29. PubMed ID: 6348901
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effects of angiotensin II analogue on rabbits with acute and chronic two-kidney, one clip hypertension (author's transl)].
    Yamasaki S, Nakatani H, Kusunoki K, Kawashima T, Kawamura H, Ohara T, Shintani H, Taniguchi N, Nagai T.
    Nihon Jinzo Gakkai Shi; 1979 Nov 08; 21(11):1251-63. PubMed ID: 396405
    [No Abstract] [Full Text] [Related]

  • 40. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC, Frohlich ED, de Carvalho JG, Dunn FG, Chrysant SG, Danisa K, Wambach G.
    Kidney Int Suppl; 1979 Mar 08; (9):S68-74. PubMed ID: 289866
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.